title: Plasma kallikrein promotes epidermal growth factor receptor transactivation and signaling in vascular smooth muscle through direct activation of protease-activated receptors.
abstract: The kallikrein-kinin system, along with the interlocking renin-angiotensin system, is a key regulator of vascular contractility and injury response. The principal effectors of the kallikrein-kinin system are plasma and tissue kallikreins, proteases that cleave high molecular weight kininogen to produce bradykinin. Most of the cellular actions of kallikrein (KK) are thought to be mediated by bradykinin, which acts via G protein-coupled B1 and B2 bradykinin receptors on VSMCs and endothelial cells. Here, we find that primary aortic vascular smooth muscle but not endothelial cells possess the ability to activate plasma prekallikrein. Surprisingly, exposing VSMCs to prekallikrein leads to activation of the ERK1/2 mitogen-activated protein kinase cascade via a mechanism that requires kallikrein activity but does not involve bradykinin receptors. In transfected HEK293 cells, we find that plasma kallikrein directly activates G protein-coupled protease-activated receptors (PARs) 1 and 2, which possess consensus kallikrein cleavage sites, but not PAR4. In vascular smooth muscles, KK stimulates ADAM (a disintegrin and metalloprotease) 17 activity via a PAR1/2 receptor-dependent mechanism, leading sequentially to release of the endogenous ADAM17 substrates, amphiregulin and tumor necrosis factor-α, metalloprotease-dependent transactivation of epidermal growth factor receptors, and metalloprotease and epidermal growth factor receptor-dependent ERK1/2 activation. These results suggest a novel mechanism of bradykinin-independent kallikrein action that may contribute to the regulation of vascular responses in pathophysiologic states, such as diabetes mellitus.
authors.affiliation: Department of Medicine, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
authors.forename: Rany T
authors.initials: RT
authors.lastname: Abdallah
authors.forename: Joo-Seob
authors.initials: JS
authors.lastname: Keum
authors.forename: Hesham M
authors.initials: HM
authors.lastname: El-Shewy
authors.forename: Mi-Hye
authors.initials: MH
authors.lastname: Lee
authors.forename: Bing
authors.initials: B
authors.lastname: Wang
authors.forename: Monika
authors.initials: M
authors.lastname: Gooz
authors.forename: Deirdre K
authors.initials: DK
authors.lastname: Luttrell
authors.forename: Louis M
authors.initials: LM
authors.lastname: Luttrell
authors.forename: Ayad A
authors.initials: AA
authors.lastname: Jaffa
mesh_terms: D051722:ADAM Proteins / Q000235:genetics / Q000378:metabolism; D000072198:ADAM17 Protein; D066258:Amphiregulin; D000818:Animals; D003920:Diabetes Mellitus / Q000235:genetics / Q000378:metabolism; D066255:EGF Family of Proteins; D004789:Enzyme Activation / Q000187:drug effects / Q000502:physiology; D066246:ErbB Receptors / Q000235:genetics / Q000378:metabolism*; D006023:Glycoproteins / Q000235:genetics / Q000378:metabolism; D057809:HEK293 Cells; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000235:genetics / Q000378:metabolism; D007610:Kallikreins / Q000378:metabolism* / Q000494:pharmacology; D020935:MAP Kinase Signaling System / Q000187:drug effects / Q000502:physiology*; D019950:Mitogen-Activated Protein Kinase 1 / Q000235:genetics / Q000378:metabolism*; D048052:Mitogen-Activated Protein Kinase 3 / Q000235:genetics / Q000378:metabolism*; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D044463:Receptor, PAR-1 / Q000235:genetics / Q000378:metabolism*; D044464:Receptor, PAR-2 / Q000235:genetics / Q000378:metabolism*; D018179:Receptors, Thrombin / Q000235:genetics / Q000378:metabolism; D015533:Transcriptional Activation / Q000187:drug effects / Q000502:physiology*
chemical_list: C587848:AREG protein, human; D066258:Amphiregulin; C587850:Areg protein, rat; D066255:EGF Family of Proteins; D006023:Glycoproteins; D036341:Intercellular Signaling Peptides and Proteins; D044463:Receptor, PAR-1; D044464:Receptor, PAR-2; D018179:Receptors, Thrombin; C512478:EGFR protein, human; C483803:Egfr protein, rat; D066246:ErbB Receptors; C535150:MAPK1 protein, human; D019950:Mitogen-Activated Protein Kinase 1; D048052:Mitogen-Activated Protein Kinase 3; D007610:Kallikreins; D051722:ADAM Proteins; D000072198:ADAM17 Protein; C000606462:ADAM17 protein, human; C000606464:Adam17 protein, rat; C112908:protease-activated receptor 4
references.citation: J Clin Invest. 1989 May;83(5):1774-7
references.pmid: 2540223
references.citation: Circ Res. 1994 Dec;75(6):1029-38
references.pmid: 7955141
references.citation: J Biol Chem. 2002 Apr 12;277(15):12838-45
references.pmid: 11823465
references.citation: Biol Chem. 2008 Jun;389(6):643-51
references.pmid: 18627296
references.citation: Circulation. 1996 Dec 1;94(11):2778-86
references.pmid: 8941102
references.citation: J Invest Dermatol. 2008 Jan;128(1):18-25
references.pmid: 17625593
references.citation: Thromb Haemost. 2008 Feb;99(2):305-15
references.pmid: 18278179
references.citation: J Pharmacol Exp Ther. 2002 Feb;300(2):702-8
references.pmid: 11805236
references.citation: J Atheroscler Thromb. 2005;12(2):73-6
references.pmid: 15942116
references.citation: J Biol Chem. 1992 Mar 25;267(9):6081-5
references.pmid: 1313429
references.citation: Pharmacol Rev. 2001 Jun;53(2):245-82
references.pmid: 11356985
references.citation: J Clin Pathol. 2004 May;57(5):513-6
references.pmid: 15113859
references.citation: Arterioscler Thromb Vasc Biol. 1996 Dec;16(12):1524-31
references.pmid: 8977458
references.citation: Exp Cell Res. 2003 Mar 10;284(1):2-13
references.pmid: 12648462
references.citation: J Thromb Haemost. 2005 Aug;3(8):1800-14
references.pmid: 16102047
references.citation: J Cardiovasc Pharmacol. 1997 Nov;30(5):649-57
references.pmid: 9388048
references.citation: J Cardiovasc Pharmacol. 1993 Oct;22(4):609-16
references.pmid: 7505364
references.citation: Am J Physiol. 1994 Nov;267(5 Pt 2):H1962-7
references.pmid: 7526715
references.citation: Circ Res. 2003 Aug 22;93(4):302-10
references.pmid: 12869389
references.citation: Annu Rev Pharmacol Toxicol. 1995;35:679-705
references.pmid: 7598512
references.citation: J Biol Chem. 2006 Feb 10;281(6):3116-26
references.pmid: 16321973
references.citation: J Clin Invest. 1992 Oct;90(4):1614-21
references.pmid: 1328304
references.citation: Sci STKE. 2000 Jan 18;2000(15):pe1
references.pmid: 11865189
references.citation: Nat Rev Mol Cell Biol. 2001 Feb;2(2):127-37
references.pmid: 11252954
references.citation: Am J Physiol. 1989 Jul;257(1 Pt 2):F60-6
references.pmid: 2546445
references.citation: Am J Physiol Heart Circ Physiol. 2004 Mar;286(3):H926-32
references.pmid: 14766673
references.citation: Br J Pharmacol. 2000 Jul;130(5):1140-6
references.pmid: 10882400
references.citation: Biochem Biophys Res Commun. 1993 Nov 30;197(1):256-62
references.pmid: 8250932
references.citation: Int Immunopharmacol. 2008 Feb;8(2):161-5
references.pmid: 18182220
references.citation: Trends Endocrinol Metab. 2004 Aug;15(6):286-93
references.pmid: 15358282
references.citation: Br J Pharmacol. 2000 Dec;131(8):1635-42
references.pmid: 11139441
references.citation: J Biol Chem. 2006 Oct 27;281(43):32095-112
references.pmid: 16885167
references.citation: J Cell Biol. 2004 Mar 1;164(5):769-79
references.pmid: 14993236
references.citation: Biochem Biophys Res Commun. 2003 Feb 21;301(4):1109-15
references.pmid: 12589827
references.citation: J Cell Sci. 1999 Nov;112 ( Pt 21):3603-17
references.pmid: 10523497
references.citation: J Clin Invest. 1993 Jan;91(1):94-8
references.pmid: 8380817
references.citation: Arterioscler Thromb Vasc Biol. 2006 Sep;26(9):e133-7
references.pmid: 16840716
references.citation: Thromb Haemost. 2001 Sep;86(3):840-7
references.pmid: 11583317
references.citation: J Vasc Surg. 2003 Mar;37(3):644-9
references.pmid: 12618705
references.citation: Thromb Haemost. 1995 Nov;74(5):1340-7
references.pmid: 8607120
references.citation: Lab Invest. 2005 Jan;85(1):9-23
references.pmid: 15568038
references.citation: Am J Physiol. 1993 Feb;264(2 Pt 2):F322-7
references.pmid: 8447442
references.citation: Trends Pharmacol Sci. 1999 Oct;20(10):408-12
references.pmid: 10577253
references.citation: Br J Pharmacol. 2008 Mar;153 Suppl 1:S263-82
references.pmid: 18059329
references.citation: J Mol Endocrinol. 2003 Apr;30(2):117-26
references.pmid: 12683936
references.citation: J Clin Invest. 2002 Apr;109(8):1007-9
references.pmid: 11956236
references.citation: Circulation. 1996 Jul 1;94(1):44-51
references.pmid: 8964116
references.citation: J Biol Chem. 1994 Mar 4;269(9):6399-404
references.pmid: 8119989
references.citation: Blood Coagul Fibrinolysis. 1995 Dec;6(8):753-60
references.pmid: 8825227
references.citation: Thromb Haemost. 1999 May;81(5):808-14
references.pmid: 10365757
references.citation: Immunopharmacology. 1999 Dec;45(1-3):135-9
references.pmid: 10615002
references.citation: Eur J Pharmacol. 1998 Jun 12;351(1):67-77
references.pmid: 9698207
references.citation: Mol Cell Proteomics. 2005 May;4(5):626-36
references.pmid: 15705970
references.citation: Atherosclerosis. 2006 Jul;187(1):82-91
references.pmid: 16214147
references.citation: Atherosclerosis. 2006 May;186(1):38-53
references.pmid: 16076471
references.citation: Hypertension. 1997 Mar;29(3):757-62
references.pmid: 9052892
references.citation: J Biol Chem. 2008 May 2;283(18):12293-304
references.pmid: 18308730
references.citation: Thromb Haemost. 2007 Jul;98(1):77-83
references.pmid: 17597995
references.citation: Ann N Y Acad Sci. 2001 Dec;947:42-54; discussion 54-5
references.pmid: 11795306
references.citation: Physiol Rev. 2004 Apr;84(2):579-621
references.pmid: 15044683
references.citation: J Neurochem. 2008 Nov;107(3):855-70
references.pmid: 18778305
references.citation: Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):27-36
references.pmid: 17095716
references.citation: Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):685-8
references.pmid: 16556862
references.citation: Blood. 1998 Jan 15;91(2):516-28
references.pmid: 9427705
references.citation: Diabetes. 2003 May;52(5):1215-21
references.pmid: 12716755
references.citation: Am J Physiol Regul Integr Comp Physiol. 2003 Jul;285(1):R1-13
references.pmid: 12793984